CHICAGO -- Physicians debated the idea of the American Medical Association (AMA) supporting a registry to track adverse ...

The pharmaceutical industry stands at a critical juncture as the European Medicines Agency (EMA) advances its implementation of ISO Identification of Medicinal Products (IDMP) standards through the ...

Following global reports of serious adverse events in older people, the government’s independent expert advisory body, the UK ...

Spread mainly by fruit bats, Nipah virus is fatal in up to 85% of cases. Symptoms include fever, headaches, pain, vomiting ...

Pharmacovigilance Risk Assessment Committee (PRAC) has concluded its review of semaglutide-containing medicines, confirming a ...

Amvuttra is the first and only RNA interference (RNAi) therapeutic approved by the EC for both the cardiomyopathy and the ...

Couple campaigning for the Government to sanction pay for a new drug called givinostat, which slows down muscle-wasting ...

SIFI, a leading international ophthalmic company, today announced that its shareholders have signed an agreement, subject to conditions precedent, to sell 100% of SIFI shares to Faes Farma, a leading ...

Alnylam Pharmaceuticals’ Amvuttra (vutrisiran) has been approved by the European Commission (EC) to treat adults with ...

Results from the study’s open-label period, presented at this year’s European Renal Association Congress, showed that ...

A demonstration by a number of doctors and other supporters was held today outside the Medical Council in Dublin in support ...